Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty

Clinical trial NCT00667446 · COMPLETED

Trial details

NCT number: NCT00667446
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Precocious Leuprolide Acetate Luteinizing Hormone (LH)Gonadotrophin-releasing Hormone Agonist (GnRHa)Tanner Staging Depot Formulation Suppression of LH Central Precocious Puberty (CPP)Gonadotrophin-releasing Hormone (GnRH)Lupron GnRH Analog Pediatrics Central Precocious Puberty

Start date: 2008-12-01
Primary completion: 2012-10-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.